A_map_of_New_England,_being_the_first_that_ever_was_here_cut_..._places_(2675732378).jpg
Robert Whitcomb Robert Whitcomb

Mass. lawsuit unveils aspects of how the Sackler family reaped a vast fortune off OxyContin

The Sackler family, famously obsessed with raising their social status, have given most of their charitable gifts to already rich elite institutions. Here, for example, is the Sackler Building at Harvard.

The Sackler family, famously obsessed with raising their social status, have given most of their charitable gifts to already rich elite institutions. Here, for example, is the Sackler Building at Harvard.

By Christine Willmsen, WBUR  and Martha Bebinger, WBUR

Via Kaiser Health News

BOSTON

The first nine months of 2013 started off as a banner year for the Sackler family, owners of the pharmaceutical company that produces OxyContin, the addictive opioid pain medication. Stamford, Conn.-based Purdue Pharma paid the family $400 million from its profits during that time, claims a lawsuit filed by the Massachusetts attorney general.

However, when profits dropped in the fourth quarter, the family allegedly supported the company’s intense push to increase sales representatives’ visits to doctors and other prescribers.

Purdue had hired a consulting firm to help reps target “high-prescribing” doctors, including several in Massachusetts. One physician in a town south of Boston wrote an additional 167 prescriptions for OxyContin after sales representatives increased their visits, according to the latest version of the lawsuit filed Thursday in Suffolk County Superior Court in Boston.

The lawsuit claims Purdue paid members of the Sackler family more than $4 billion between 2008 and 2016. Eight members of the family who served on the board or as executives as well as several directors and officers with Purdue are named in the lawsuit. This is the first lawsuit among hundreds of others that were previously filed across the country to charge the Sacklers with personally profiting from the harm and death of people taking the company’s opioids.

WBUR along with several other media sued Purdue Pharma to force the release of previously redacted information that was filed in the Massachusetts Superior Court case. When a judge ordered the records to be released with few, if any, redactions this week, Purdue filed two appeals and lost.

The complaint filed by Massachusetts Atty. Gen. Maura Healey says that former Purdue Pharma CEO Richard Sackler allegedly suggested the family sell the company or, if they weren’t able to find a buyer, to milk the drugmaker’s profits and “distribute more free cash flow” to themselves.

That was in 2008, one year after Purdue pleaded guilty to a felony and agreed to stop misrepresenting the addictive potential of its highly profitable painkiller, OxyContin.

At a board meeting in June 2008, the complaint says, the Sacklers voted to pay themselves $250 million. Another payment in September totaled $199 million.

The company continued to receive complaints about OxyContin similar to those that led to the 2007 guilty plea, according to unredacted documents filed in the case.

While the company settled lawsuits in 2009 totaling $2.7 million brought by family members of those who had been harmed by OxyContin throughout the country, the company amped up its marketing of the drug to physicians by spending $121.6 million on sales reps for the coming year. The Sacklers paid themselves $335 million that year.

The lawsuit claims that Sackler family members directed efforts to boost sales. An attorney for the family and other board directors is challenging the authority to make that claim in Massachusetts. A motion on jurisdiction in the case hasn’t been heard. That attorney hasn’t responded to a request for comment on the most recent allegations.

Purdue Pharma, in a statement, said the complaint filed by Healey is “part of a continuing effort to single out Purdue, blame it for the entire opioid crisis, and try the case in the court of public opinion rather than the justice system.”

Purdue went on to charge Healey with attempting to “vilify” Purdue in a complaint “riddled with demonstrably inaccurate allegations.” Purdue said it has more than 65 initiatives aimed at reducing the misuse of prescription opioids. The company says Healey fails to acknowledge that most opioid overdose deaths are currently the result of fentanyl.

Purdue fought the release of many sections of the 274-page complaint. Attorneys for the company said at a hearing on Jan. 25 that they had agreed to release much more information in Massachusetts than has been cleared by a judge overseeing hundreds of cases consolidated in Ohio. Purdue filed both state and federal appeals this week to block release of the compensation figures and other information about Purdue’s plan to expand into drugs to treat opioid addiction.

The attorney general’s complaint says that in a ploy to distance themselves from the emerging statistics and studies that showed OxyContin’s addictive characteristics, the Sacklers approved public marketing plans that labeled people hurt by opioids as “junkies” and “criminals.”

Richard Sackler allegedly wrote that Purdue should “hammer” them in every way possible.

While Purdue Pharma publicly denied its opioids were addictive, internally company officials were acknowledging it and devising a plan to profit off them even more, the complaint states.

Kathe Sackler, a board member, pitched “Project Tango,” a secret plan to grow Purdue beyond providing painkillers by also providing a drug, Suboxone, to treat those addicted.

“Addictive opioids and opioid addiction are ‘naturally linked,'” she allegedly wrote in September 2014.

According to the lawsuit, Purdue staff wrote: “It is an attractive market. Large unmet need for vulnerable, underserved and stigmatized patient population suffering from substance abuse, dependence and addiction.”

They predicted that 40-60 percent of the patients buying Suboxone for the first time would relapse and have to take it again, which meant more revenue.

Purdue never went through with it, but Attorney General Healey contends that this and other internal documents show the family’s greed and disregard for the welfare of patients.

This story is part of a reporting partnership between WBUR, NPR and Kaiser Health News.

A version of this story first ran on WBUR’s CommonHealth. You can follow @mbebinger on Twitter.



Read More
RWhitcomb-editor RWhitcomb-editor

James P. Freeman: Why Mass. AG Healey should be ousted

In his dutiful and forceful concession remarks in November 2014, John Miller, the Republican candidate that year for Massachusetts attorney general, gave fair warning: “The fight for impartial, fact-based justice from a non-partisan attorney general goes on.” Miller, even in defeat, believed – and presumably feared — that the Bay State was still in “desperate need” of an attorney general who would take a “professional, not a political approach” to the office.

His fears are confirmed.

In June of 2016, it is now evident that the winner that November night, Maura Healey, is using her office to punish those whose views of public policy differ from her own. As a consequence, Healey is no longer fit to hold the office of attorney general.

 

As reported last week, Healey is now using the power of her office to investigate conservative groups with supposed ties to ExxonMobil. Her subpoena charges that the oil giant lied to shareholders and consumers about the risks of global warming in its communications and shareholder filings.

Healey is seeking 40 years-worth of ExxonMobil documents and communications with right-leaning “think tanks.” Locally, these include the Beacon Hill Institute and Acton Institute. According to The Boston Herald, the basis of the investigation is “deceptive business practices.” The energy company countered by filing a federal lawsuit claiming, rightly, that Healey’s action is no more than a “fishing expedition,” part of a “political agenda,” and the attorney general is “abusing the power of government.” It is a disgracefully overt political maneuver.

Remarkably, both the Left and Right have been critical of state attorneys-general engaged in this scrutiny of ExxonMobil. Harvey Silverglate, former president of the American Civil Liberties Union in Massachusetts, called the investigation “pure harassment.” Added Silverglate, “It’s not the way scientific or factual or even political battles are settled in this country, which last I checked is still a free country.” The Wall Street Journal’s Kimberley Strassel wrote that the attack on ExxonMobil is really a “front,” and that the real target is “a broad array of conservative activist groups.”

So this is what we have come to in Massachusetts: a hyper-partisan attorney general, motivated by political expediency, who believes that ExxonMobil defrauded the public and its shareholders by systematically advancing the idea of “climate denial.” Seriously.

Where is the outrage on Beacon Hill? Where is the outrage from the prestige media in greater Boston?

Perhaps more so than any other Massachusetts elected official – including Sen. Elizabeth Warren — Healey is the penultimate programmed progressive. Her core belief-system centers around identity politics and so-called diversity… of everything; except political thought.

On her Web site, maurahealey.com, Healy calls herself the “People’s Lawyer” (she is, apparently, the lawyer of all of the people, except, that is, conservative people). In a January posting she brags that she is “looking ahead to the challenges around the bend and we’re already pushing hard on our top priorities.” ExxonMobil’s thoughts on so-called climate disruption are a priority for the people of Massachusetts?

Healey’s behavior is reminiscent of the Lois Lerner and IRS scandal from a few years ago. Then, as now, conservative groups were targeted under a legal pretense. If Healey’s actions were based in fact and based on the law, warranting the full force and authority of her office, why hasn’t she called for the complete divestiture of ExxonMobil investments by the state’s pension system (which in 2015 was valued at $151 million in the Domestic Equity portfolio)?

 

Among the first official undertakings by Healey in 2015 was a social-media “campaign.” It involved the collection of testimonials from same-sex couples for an amicus brief that was filed with the U.S. Supreme Court, supporting national recognition of gay marriage. However laudable, such time and expense amounted to a political lagniappe but not a legal imperative.

In Massachusetts, it seems identity politics is a greater priority than identity theft, which should be a priority.

Identity theft – the unauthorized use of personal information to defraud or commit crimes – is the fastest-growing crime in America. The Massachusetts Executive Office of Public Safety and Security notes that victims spend “between 30-60 hours of their time” and “approximately $1,000 of their own money clearing up the problem.”

The Boston Globe noted two years ago that 1.2 million people in the Commonwealth had personal information and financial data compromised in 2013. In February 2015, a “data breach” occurred at insurer Anthem, compromising personal information of 78.8 million Americans. One million of those reside in Massachusetts.

But don’t tell that to Healey.

On mass.gov/ago, victims are cautioned: “You should be aware that not all identity-theft complaints can or will be investigated.” These people, unlike ExxonMobil, will likely not be accorded a vigorous campaign. What is unsettling is that Healey and fellow progressives believe they can effectively combat climate disruption to their satisfaction but not identity theft.

Healey will probably not resign from office. She also probably not be impeached under the articles of the Constitution of the Commonwealth of Massachusetts. As a last resort, however, she should be recalled. Interestingly, the voter initiative and referendum provisions in the constitution specifically exclude the recall/removal of judges. But the Constitution is silent regarding recall/removal of executive branch officers.

Let the petition begin.

James P. Freeman is a columnist for The New Boston Post.

Read More